Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BY 4.0PLOS One

Integrated In vitro and in vivo evaluation of anticancer potentials of two clerodane diterpenes isolated from Psidium guajava (L.) through molecular docking approaches

  1. 1Department of Pharmacy, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Santosh, Tangail, Bangladesh
  2. 2Department of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi, Bangladesh
  3. 3Department of Pharmacy, School of Pharmaceutical Sciences, State University of Bangladesh, Dhaka, Bangladesh

Abstract

Psidium guajava (L.) is a medicinal plant rich in bioactive phytochemicals with promising therapeutic potential. This study aimed to isolate clerodane-type diterpenes from P. guajava and evaluate their anticancer activity through in vitro and in vivo assays supported by molecular docking.Two clerodane-type diterpenes, borapetoside F (1) and borapetoside B (2), were isolated from the ethyl acetate fraction of P. guajava and identified by 1H and 13C NMR spectroscopy. Cytotoxicity was evaluated against Ehrlich Ascites Carcinoma (EAC) cells using the MTT assay and in EAC-bearing Swiss albino mice, with bleomycin as the reference drug. Apoptosis was assessed by microscopy, DNA fragmentation, gene expression analysis. Compounds 1 and 2 demonstrated significant in vitro cytotoxicity, inhibiting EAC cell growth by 82.4% and 79.8%, respectively. In in vivo cytotoxicity assays, these compounds suppressed EAC cell proliferation by 61.26% and 48.88%, respectively. Optical and fluorescence microscopy revealed characteristic apoptotic morphological changes, while DNA fragmentation analysis confirmed apoptosis induction. Gene expression analysis demonstrated upregulation of the pro-apoptotic markers p53, Bax, and Cytochrome C, accompanied by downregulation of the anti-apoptotic genes Bcl-2 and NF-κB. Molecular docking further supported the experimental findings by demonstrating favorable interactions of both compounds with apoptosis-related target proteins. Collectively,. Borapetoside F (1) and borapetoside B (2) exhibit significant anticancer activity by inhibiting EAC cell proliferation and inducing apoptosis, suggesting their potential as promising lead compounds for anticancer drug development.

Related

  1. Evaluation of the Anticancer Potential of Compound 107 via the VEGFA and VEGFR2 (KDR) Signaling Pathway in Colorectal Cancer: Integrative Analysis of Clinical, In Silico, and In Vitro Approaches
    Ayca Tas, Cemile Zontul, Gökhan Dogan +11
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  2. Combining Ligand- and Structure-Based Approaches to Develop Haloacetamide-Derived Di(hetero)arylmethanes as Potential Anticancer Agents
    Karina O. Shibaeva, Andrey V. Smolobochkin, Elena A. Chugunova +12
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. In Vitro Anticancer Activity and Integrated Multi-Target Computational Analysis of Ylang-Ylang Essential Oil Against Breast Cancer
    Mohamed Chebaibi, Amine Elbouzidi, Mohamed Taibi +10
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  4. Targeting the ERK2 D-Recruitment Site with Anticancer Peptides from the DRAMP Database: An Integrated In Silico Study
    Nahlah Makki Almansour, Mahmoud A. A. Ibrahim
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  5. Integrated immunoinformatics and molecular dynamics approaches reveal a promising multi-epitope vaccine against hantavirus
    Shahid Ullah, Alex Tonks, Carlos Eliel Maya-Ramírez +5
    In Silico PharmacologyPeer-reviewedLicence not statedFull textMolecular biology & gene regulationPMC
BibTeX
@article{khatun2026integrated,
  title = {{Integrated In vitro and in vivo evaluation of anticancer potentials of two clerodane diterpenes isolated from Psidium guajava (L.) through molecular docking approaches}},
  author = {Most Chand Sultana Khatun and Mir Imam Ibne Wahed and Md. Jamal Hossain and Md. Ataur Rahman and Sabbir Ahmed and Md Hasibul Hasan},
  journal = {PLOS One},
  year = {2026},
  month = nov,
  doi = {10.1371/journal.pone.0362655},
  url = {https://doi.org/10.1371/journal.pone.0362655},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Integrated In vitro and in vivo evaluation of anticancer potentials of two clerodane diterpenes isolated from Psidium guajava (L.) through molecular docking approaches
AU  - Most Chand Sultana Khatun
AU  - Mir Imam Ibne Wahed
AU  - Md. Jamal Hossain
AU  - Md. Ataur Rahman
AU  - Sabbir Ahmed
AU  - Md Hasibul Hasan
PY  - 2026
DA  - 2026/11/13
JO  - PLOS One
DO  - 10.1371/journal.pone.0362655
UR  - https://doi.org/10.1371/journal.pone.0362655
AB  - Psidium guajava (L.) is a medicinal plant rich in bioactive phytochemicals with promising therapeutic potential. This study aimed to isolate clerodane-type diterpenes from P. guajava and evaluate their anticancer activity through in vitro and in vivo assays supported by molecular docking.Two clerodane-type diterpenes, borapetoside F (1) and borapetoside B (2), were isolated from the ethyl acetate fraction of P. guajava and identified by 1H and 13C NMR spectroscopy. Cytotoxicity was evaluated against Ehrlich Ascites Carcinoma (EAC) cells using the MTT assay and in EAC-bearing Swiss albino mice, with bleomycin as the reference drug. Apoptosis was assessed by microscopy, DNA fragmentation, gene expression analysis. Compounds 1 and 2 demonstrated significant in vitro cytotoxicity, inhibiting EAC cell growth by 82.4% and 79.8%, respectively. In in vivo cytotoxicity assays, these compounds suppressed EAC cell proliferation by 61.26% and 48.88%, respectively. Optical and fluorescence microscopy revealed characteristic apoptotic morphological changes, while DNA fragmentation analysis confirmed apoptosis induction. Gene expression analysis demonstrated upregulation of the pro-apoptotic markers p53, Bax, and Cytochrome C, accompanied by downregulation of the anti-apoptotic genes Bcl-2 and NF-κB. Molecular docking further supported the experimental findings by demonstrating favorable interactions of both compounds with apoptosis-related target proteins. Collectively,. Borapetoside F (1) and borapetoside B (2) exhibit significant anticancer activity by inhibiting EAC cell proliferation and inducing apoptosis, suggesting their potential as promising lead compounds for anticancer drug development.
SN  - 1932-6203
ER  -